Effects of Rhythmic Motor and Behavioral Intervention on Motor and Social Performance in Preschool Children with Autism Spectrum Disorder: A Pilot Randomized Controlled Study.

J Autism Dev DisordJun 11, 2025 (epub)
Clinical ResearchPediatricsPsychiatryOpen access

Pou-Leng Cheong, Yen-Tzu Wu, Li-Nian Xie et al.

✦ AI-curated · Sources linked

In 30 seconds

This pilot randomized controlled study evaluated an 8-week Rhythmic Motor and Behavioral Intervention (RMBI) in 30 preschool children with autism spectrum disorder (median age 5.8 years; 20 males). Children were assigned to RMBI, combining music-based rhythmic motor activities with parent education in Pivotal Response Treatment (PRT), or to a control group whose parents received PRT education only. The RMBI group showed medium-to-large improvements in several gross motor domains and significant improvements in autistic symptoms and social communication. Imitation accuracy and movement synchrony also improved from baseline. The findings are preliminary and require confirmation.

Key findings

  • The RMBI group showed medium-to-large improvements in stationary and locomotor skills, visual-motor integration, and balance.
  • Significant improvements in autistic symptoms and social communication abilities were reported in the RMBI group.
  • Children receiving RMBI improved in imitation accuracy and movement synchrony compared with their baseline performance.

Why it matters

Motor, imitation, and social communication outcomes were assessed together in preschool children with ASD, suggesting that a combined rhythmic motor and parent-education program may have benefits across these domains. The results offer preliminary support for further evaluation of an intervention that integrates movement activities with behavioral parent education, while not establishing its effectiveness beyond this small pilot study.

What to keep in mind

This was a pilot study with 30 children, and the authors state that larger samples and longer follow-up are needed to confirm efficacy and generalizability.

Source

Published in J Autism Dev Disord. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Pediatrics

Clinical ResearchOncology (Medical)

Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.

DALY 2-EU was an open-label, multicentre, randomised phase 2 trial comparing tandem CD20-CD19-directed zamtocabtagene autoleucel (zamto-cel) with R-GemOx in adults with second-line relapsed or refractory large B-cell…

Lancet OncolOct 27, 2026Read summary
Clinical ResearchOncology (Medical)

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial.

UNION was a multicentre, open-label, randomised phase 3 trial at nine hospitals in China comparing neoadjuvant short-course radiotherapy followed by camrelizumab plus CAPOX with long-course chemoradiotherapy followed by…

Lancet OncolOct 25, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.